Callio Therapeutics raised $187M in a Series A funding round led by Frazier Life Sciences to expand operations and development efforts.
Amount Raised
$187 Million
Round Type
Series A
SeattleBiotechnologyHealth CareTherapeuticsInvestors
Description
Callio Therapeutics, a biotechnology company focused on developing multi-payload antibody-drug conjugates for cancer therapy, raised $187M in Series A funding. The funds will be used to expand operations and development efforts.
Quick answer
Callio Therapeutics raised $187 Million in a Series A round, dated March 3, 2025. Investors: Edbi, Norwest Venture Partners, ClavystBio, Jeito Capital, Novo Holdings A/S, Omega Funds, Platanus and Pureos Bioventures. Callio Therapeutics is based in Seattle, Washington, United States.
- How much did Callio Therapeutics raise?
- Callio Therapeutics raised $187 Million in a Series A round on March 3, 2025.
- Who invested in Callio Therapeutics?
- Edbi, Norwest Venture Partners, ClavystBio, Jeito Capital, Novo Holdings A/S, Omega Funds, Platanus and Pureos Bioventures are named as investors in this round.
- What does Callio Therapeutics do?
- Callio Therapeutics is a biotechnology company focused on realizing the promise of multi-payload antibody-drug conjugates (ADC) to enhance cancer therapy.
- Where is Callio Therapeutics based and how big is it?
- Callio Therapeutics is based in Seattle, Washington, United States. Fundz records about 23 employees.
- Who are the decision-makers at Callio Therapeutics?
- Fundz holds 1 contact at Callio Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Callio Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Pathos AI raised $283M on April 17, 2025.
- Lobe Sciences raised $6M (Series A) on April 14, 2025.
- Decoy Therapeutics raised $1.2M (Seed) on April 11, 2025.
- OncoNano Medicine raised $13M on April 11, 2025.
- Merida Therapeutics raised $121M (Series A) on April 8, 2025.
- Accure Therapeutics S.L raised $1.6M (Seed) on April 7, 2025.
Who to call at Callio Therapeutics, and when
A new round usually means Callio Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Callio Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Callio Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Callio Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Callio Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansCallio Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.